Anti-cMet/anti-EGFR/anti-HER3 multispecific antibodies and use thereof
US10000569B2 · kind B2 · utility
2Cited by
2References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 22, 2015 |
| Grant date | Jun 19, 2018 |
| Priority date | — |
| Expiry date | Apr 22, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N15/09
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An anti-EGFR/anti-HER3 antibody or antigen binding fragment thereof, and a method of preventing and/or treating a cancer using the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.